Product Information
Name:Cyslt1 antagonist Q8
Brand:Biosynth
Description:Cyslt1 is a receptor tyrosine kinase that has been implicated in the development of colorectal cancer. Cyslt1 antagonist Q8 is an antibody that binds to the extracellular domain of cyslt1 and prevents it from binding to epidermal growth factor (EGF), which blocks its signaling. The inhibition of EGF signaling by Cyslt1 antagonist Q8 leads to diminished cancer cell proliferation and colony formation, decreased tumor size, and increased apoptosis. Cyslt1 antagonist Q8 also inhibits the production of TNF-α and VEGF in colon cancer cells, leading to decreased metastasis. This drug may be useful for the treatment of metastatic colorectal cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:299.7 g/mol
Formula:C17H14ClNO2
Purity:Min. 95%
Technical inquiry about: Cyslt1 antagonist Q8
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.